Active	Status	Sponsor type	Region	Phase	Filter
1 Active 23 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
lidocaine (ARC-2022) / Arcion
ACTRN12610000143022: Ascending dose of 40 % Lidocaine Gel applied to patients with Postherpetic Neuralgia.	Recruiting	N/A	30			Nucleus Network, Arcion Therapeutics, Inc	Herpes Zoster (shingle)
clonidine (ARC 4558) / Collegium Pharma
No trials found
Adlea (capsaicin) / Arcion, Centrexion Therap
No trials found